U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 16 results

Status:
US Approved Rx (2019)
First approved in 1998

Class (Stereo):
CHEMICAL (ACHIRAL)



Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID). It works by reducing hormones that cause inflammation and pain in the body. Celecoxib is an analgesic that is FDA approved for the treatment of osteoarthritis,rheumatoid arthritis,juvenile r...
Status:
US Approved Rx (1993)
First approved in 1986

Class (Stereo):
CHEMICAL (ABSOLUTE)



Dexketoprofen is a nonsteroidal anti-inflammatory drug (NSAID), manufactured by Menarini under the tradename Keral. Dexketoprofen is indicated for short-term treatment of mild to moderate pain, including dysmenorrhoea. Dexketoprofen works by blockin...
Status:
US Approved Rx (1986)
First approved in 1980

Class (Stereo):
CHEMICAL (ACHIRAL)



Meclofenamic acid, used as Meclofenamate sodium, is a non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. Meclofenamate sodium capsules are indicated for the relief of mild to moderate pain, for the treatment of pri...
Status:
US Approved Rx (2014)
First approved in 1967

Class (Stereo):
CHEMICAL (ACHIRAL)



Mefenamic acid is a non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is used for the treatment of mild to moderate pain, including menstrual pain, inflammation, and fever. Clinical use of mefenam...
Status:
US Previously Marketed
First approved in 2001

Class (Stereo):
CHEMICAL (ACHIRAL)



Valdecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, is classified as a nonsteroidal anti-inflammatory drug (NSAID). Valdecoxib was manufactured and marketed under the brand name Bextra. Bextra was indicated for relief of the signs and symptom...
Status:
US Previously Marketed
First approved in 1999

Class (Stereo):
CHEMICAL (ACHIRAL)



Rofecoxib is a nonsteroidal anti-inflammatory drug which selectively inhibits COX-2 and subsequent prostaglandin synthesis. The drug was developed by Merk and approved by FDA in 1999 for relief of signs and symptoms of arthritis, acute pain in adults...
Status:
Possibly Marketed Outside US

Class (Stereo):
CHEMICAL (ACHIRAL)



Nimesulide is a relatively COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. Its approved indications are the second line treatment of acute pain and primary dysmenorrhoea. Due to concerns about ...
Status:
US Approved Rx (1993)
First approved in 1986

Class (Stereo):
CHEMICAL (RACEMIC)



Dexketoprofen is a nonsteroidal anti-inflammatory drug (NSAID), manufactured by Menarini under the tradename Keral. Dexketoprofen is indicated for short-term treatment of mild to moderate pain, including dysmenorrhoea. Dexketoprofen works by blockin...
Status:
US Approved Rx (1993)
First approved in 1986

Class (Stereo):
CHEMICAL (RACEMIC)



Dexketoprofen is a nonsteroidal anti-inflammatory drug (NSAID), manufactured by Menarini under the tradename Keral. Dexketoprofen is indicated for short-term treatment of mild to moderate pain, including dysmenorrhoea. Dexketoprofen works by blockin...
Status:
US Approved Rx (1993)
First approved in 1986

Class (Stereo):
CHEMICAL (ABSOLUTE)



Dexketoprofen is a nonsteroidal anti-inflammatory drug (NSAID), manufactured by Menarini under the tradename Keral. Dexketoprofen is indicated for short-term treatment of mild to moderate pain, including dysmenorrhoea. Dexketoprofen works by blockin...

Showing 1 - 10 of 16 results